MAGNI, MARTINA
MAGNI, MARTINA
Dipartimento di Oncologia ed Emato-Oncologia
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study
2025 F. Stella, A. Chiappella, M. Magni, F. Bonifazi, C. De Philippis, M. Musso, I. Cutini, S. Ljevar, A.M. Barbui, M. Farina, M. Martino, M. Massaia, G. Grillo, P. Angelillo, B. Botto, F. Patriarca, M. Krampera, L. Arcaini, M.C. Tisi, P. Zinzani, F. Sorà, S. Bramanti, M. Pennisi, C. Carniti, P. Corradini
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study
2024 A. Chiappella, B. Casadei, P. Chiusolo, A. Di Rocco, S. Ljevar, M. Magni, P. Angelillo, A.M. Barbui, I. Cutini, A. Dodero, F. Bonifazi, M.C. Tisi, S. Bramanti, M. Musso, M. Farina, M. Martino, M. Novo, G. Grillo, F. Patriarca, G. Zacchi, M. Krampera, M. Pennisi, E. Galli, M. Martelli, A.J.M. Ferreri, S. Ferrari, R. Saccardi, A. Bermema, A. Guidetti, R. Miceli, P.L. Zinzani, P. Corradini
Phenotypic composition of commercial anti-CD19 CAR-T cells affects in vivo expansion and disease response in large B-cell lymphoma patients
2022 C. Monfrini, F. Stella, V. Aragona, M. Magni, S. Ljevar, C. Vella, E. Fardella, A. Chiappella, F. Nanetti, M. Pennisi, A. Dodero, A. Guidetti, P. Corradini, C. Carniti